| 21/190 |
Treatment Medications |
| 21/188 |
Agency Spend and Hours |
| 21/187 |
Occupational Health |
| 21/186 |
Biologic and Biosimilar Products within Rheumatology |
| 21/185 |
Melanoma Skin Cancer information |
| 21/184 |
Orthotics |
| 21/183 |
Clotting Disorders |
| 21/182 |
Chronic Heart Failure Guidelines |
| 21/181 |
Trust Agreements With Earnd |
| 21/180 |
Numbers of Suicides |
| 21/179 |
Patient-Safety Incidents |
| 21/177 |
New Biologic Medications |
| 21/176 |
Staff Expenditure |
| 21/175 |
Electronic Document Management System |
| 21/174 |
Diabetes Insulin Pump Service |
| 21/173 |
Covid 19 Deaths |
| 21/172 |
Deaths Relating to Influenza and Covid-19 |
| 21/171 |
Royal College Invited Review |
| 21/170 |
Covid 19, Cancer & Suicide Deaths |
| 21/169 |
Quality Improvement Capability |
